|
Volumn 158, Issue PART B, 2014, Pages 467-470
|
Challenges of safety evaluation
|
Author keywords
Committee on Herbal Medicinal Products (HMPC); Genotoxicity; Herbal medicinal products; Non clinical requirements; Traditional use
|
Indexed keywords
CARCINOGEN;
ESSENTIAL OIL;
GLYCOSIDASE;
HERBACEOUS AGENT;
PLANT MEDICINAL PRODUCT;
AMES TEST;
ARTICLE;
CARCINOGENICITY;
DEVELOPMENTAL TOXICITY;
DOCUMENTATION;
DRUG MARKETING;
DRUG SAFETY;
ENZYME ACTIVITY;
GENE MUTATION;
GENETIC TOXICOLOGY;
GENOTOXICITY;
HUMAN;
IMMUNOTOXICITY;
METABOLIC ACTIVATION;
MUTAGENICITY;
NONHUMAN;
PUBLICATION;
REGISTRATION;
REPRODUCTIVE TOXICITY;
RISK ASSESSMENT;
SOLVENT EXTRACTION;
ADVERSE EFFECTS;
DRUG APPROVAL;
DRUG LEGISLATION;
EUROPEAN UNION;
LEGISLATION AND JURISPRUDENCE;
PHYTOTHERAPY;
STANDARDS;
TRADITIONAL MEDICINE;
DRUG APPROVAL;
EUROPEAN UNION;
HUMANS;
LEGISLATION, DRUG;
MEDICINE, TRADITIONAL;
PHYTOTHERAPY;
PLANT PREPARATIONS;
|
EID: 84915783068
PISSN: 03788741
EISSN: 18727573
Source Type: Journal
DOI: 10.1016/j.jep.2014.08.013 Document Type: Article |
Times cited : (13)
|
References (8)
|